Combination therapy for selected sex steroid dependent cancers

Details Combination therapy for selected sex steroid dependent cancers Combination therapy for selected sex steroid dependent cancers

1989-11-09

1991-11-12

Lee, Lester L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514177, 514178, 514358, 514800, A61K 3702

Patent

active

050648136

ABSTRACT:
A combination therapy for treatment of selected sex steroid dependent cancers in susceptible warm-blooded animals comprising administering to such animals whose hormone output of their testes or ovaries, respectively, is blocked a therapeutically effective amount of an antiandrogen and/or an antiestrogen and/or at least one inhibitor of sex steroid biosynthesis or pharmaceutical compositions thereof wherein the selected sex steroid dependent cancer are, for example, testicular cancer, ovarian cancer, renal cancer or uterine cancer is disclosed.

REFERENCES:
patent: 4659695 (1987-04-01), Labrie
patent: 4666885 (1987-05-01), Labrie
patent: 4775660 (1988-10-01), Labrie
patent: 4775661 (1988-10-01), Labrie

Affiliated with

Also associated with

Rating

Combination therapy for selected sex steroid dependent cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for selected sex steroid dependent cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for selected sex steroid dependent cancers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1013130